137 Real-World Delivery, Safety and Outcomes of Quadruple Therapy (Atezolizumab, Bevacizumab, Paclitaxel and Carboplatin) in Metastatic Non-Squamous NSCLC: A Quality Improvement Review

Lung Cancer 2026

View at publisher
Authors: Anomnimechi Ugorji, Farah Shah
DOI: 10.1016/j.lungcan.2026.109086
Cited by: 0
References: 1

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
109086–109086
Publication date
1 February 2026
Language
EN